Wegovy

Novo Nordisk’s CFO reflects on ‘pressure’ to drive growth

Novo Nordisk’s CFO spoke to Fierce the morning the company unveiled its second-quarter earnings, reflecting on its “roller coaster” financial journey.

James Waldron Aug 7, 2026 9:08am

Novo Nordisk’s CFO on the oral Wegovy rollout and beyond

Aug 7, 2026 8:42am

Novo Nordisk pens GLP-1 implant tech deal with Vivani Medical

Jul 7, 2026 9:07am

Pharma money pharma money pharma profits Big Pharma sales drug sales

Fierce Pharma

Obesity meds, China drive $2T in projected 2032 drug sales: report

Jun 23, 2026 9:00am

Mike Doustdar Novo Nordisk Novo Novo CEO

Fierce Pharma

Novo Nordisk’s ‘optimistic’ CEO Doustdar sits down with Fierce

Jun 11, 2026 7:00am

Magnifying glass amplifying warning sign over falling stock figures

Novo Holdings assets shrink by 3rd as Novo Nordisk shares fall

Mar 12, 2026 7:15am